Logan Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,613
| Closed | -$116K | – | 554 |
|
|
2021
Q1 | $116K | Sell |
1,613
-143,961
| -99% | -$10.4M | 0.01% | 304 |
|
|
2020
Q4 | $10.5M | Sell |
145,574
-20,840
| -13% | -$1.09M | 0.52% | 62 |
|
|
2020
Q3 | $7.58M | Sell |
166,414
-2,610
| -2% | -$109K | 0.41% | 70 |
|
|
2020
Q2 | $7.64M | Sell |
169,024
-2,114
| -1% | -$94.7K | 0.44% | 67 |
|
|
2020
Q1 | $6.59M | Buy |
171,138
+9,736
| +6% | +$448K | 0.46% | 60 |
|
|
2019
Q4 | $7.47M | Buy |
161,402
+5,709
| +4% | +$247K | 0.41% | 71 |
|
|
2019
Q3 | $6.34M | Buy |
155,693
+1,249
| +0.8% | +$53.9K | 0.37% | 76 |
|
|
2019
Q2 | $7.44M | Buy |
154,444
+46,874
| +44% | +$2.46M | 0.44% | 69 |
|
|
2019
Q1 | $6.74M | Buy |
107,570
+53,281
| +98% | +$3.66M | 0.41% | 71 |
|
|
2018
Q4 | $3.24M | Buy |
54,289
+1,765
| +3% | +$106K | 0.26% | 101 |
|
|
2018
Q3 | $3.38M | Buy |
52,524
+2,705
| +5% | +$151K | 0.22% | 102 |
|
|
2018
Q2 | $2.24M | Buy |
49,819
+18,512
| +59% | +$738K | 0.16% | 118 |
|
|
2018
Q1 | $972K | Buy |
31,307
+12,659
| +68% | +$416K | 0.07% | 175 |
|
|
2017
Q4 | $558K | Sell |
18,648
-1,498
| -7% | -$43.4K | 0.04% | 219 |
|
|
2017
Q3 | $665K | Buy |
+20,146
| New | +$698K | 0.05% | 203 |
|
Logan Capital Management's BEAT Position: Q2 2021 in Review
Logan Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2021, closing a stake of 1,613 shares — an estimated $116K sold.
Logan Capital Management first reported a position in BEAT in Q3 2017 and held it in 15 quarters. The position peaked at $10.5M in Q4 2020. 0 funds tracked by Wall St. Rank hold BEAT as of Q2 2021.
- Logan Capital Management reported no remaining BioTelemetry, Inc. position as of Q2 2021 after selling out during the quarter.
- Logan Capital Management sold 1,613 BioTelemetry, Inc. shares in Q2 2021, an estimated $116K.
- Logan Capital Management first reported a position in BioTelemetry, Inc. in Q3 2017 and held it in 15 quarters.
- Logan Capital Management's BioTelemetry, Inc. position peaked at $10.5M in Q4 2020.
- 0 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2021.
Based on Logan Capital Management's 13F filing for Q2 2021, filed 17 Aug 2021.